<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35214624</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>21</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">165</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines10020165</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Long COVID is a condition characterized by long-term sequelae persisting after the typical convalescence period of COVID-19. Previous reports have suggested the role of an unsatisfactory immune response and impaired viral clearance in the pathogenesis of long COVID syndrome. We focused on potential associations between post-vaccination changes of antibody titers and the severity of long COVID symptoms and factors influencing the state of remission observed in patients with long COVID after vaccination.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The severity of long COVID symptoms and serum anti-SARS-CoV-2 spike (S-Ig) and nucleocapsid (NC-Ig) levels were assessed in 107 post-COVID subjects at two time points: at baseline, and 17-24 weeks later. Besides, vaccination status was also assessed. Symptoms were evaluated based on the Chalder fatigue scale (CFQ-11) and visual analogue scale (VAS).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Serum level of S-Ig and NC-Ig at baseline were significantly higher in the patients with non-severe fatigue than those with severe fatigue, and this difference remained significant at follow-up in the case of NC-Ig. NC-Ig level above median was as an independent predictor for complete remission at follow-up. The difference in NC-Ig levels in subgroup analyses (severe fatigue vs. non-severe fatigue; complete remission vs. incomplete remission or progression) was found to be significant only in patients who received vaccination.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The immune response against the SARS-CoV-2 nucleocapsid may play a more important role than the spike in the course of long-term COVID syndrome.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Varnai</LastName><ForeName>Reka</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8440-3955</Identifier><AffiliationInfo><Affiliation>Department of Primary Health Care, Medical School, University of Pecs, 7624 Pecs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molnar</LastName><ForeName>Tihamer</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-6149-9787</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Medical School, University of Pecs, 7624 Pecs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zavori</LastName><ForeName>Laszlo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1715-4167</Identifier><AffiliationInfo><Affiliation>Salisbury NHS Foundation Trust, Salisbury SP28BJ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>T&#x151;k&#xe9;s-F&#xfc;zesi</LastName><ForeName>Margit</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Medical School, University of Pecs, 7624 Pecs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Illes</LastName><ForeName>Zsolt</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Odense University Hospital, University of Southern Denmark, 5230 Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanizsai</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Dentistry, Medical School, University of Pecs, 7624 Pecs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Csecsei</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4982-2481</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Medical School, University of Pecs, 7624 Pecs, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">nucleocapsid</Keyword><Keyword MajorTopicYN="N">spike</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35214624</ArticleId><ArticleId IdType="pmc">PMC8924883</ArticleId><ArticleId IdType="doi">10.3390/vaccines10020165</ArticleId><ArticleId IdType="pii">vaccines10020165</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO  . Coronavirus (COVID-19) Dashboard. World Health Organization; Geneva, Switzerland: 2021.  [(accessed on 8 December 2021)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE COVID-19 rapid guidelines. Pharm. Outcomes News. 2021;877:33. doi: 10.1007/s40274-021-7682-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40274-021-7682-3</ArticleId><ArticleId IdType="pmc">PMC8085796</ArticleId><ArticleId IdType="pubmed">33948079</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar T., Varnai R., Schranz D., Zavori L., Peterfi Z., Sipos D., T&#x151;k&#xe9;s-F&#xfc;zesi M., Illes Z., Buki A., Csecsei P. Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms. J. Clin. Med. 2021;10:4337. doi: 10.3390/jcm10194337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10194337</ArticleId><ArticleId IdType="pmc">PMC8509483</ArticleId><ArticleId IdType="pubmed">34640355</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.T., Perrodeau E., Saldanha J., Pane I., Ravaud P. Efficacy of COVID-19 Vaccination on the Symptoms of Patients With Long COVID: A Target Trial Emulation Using Data from the ComPaRe e-Cohort in France.  [(accessed on 8 December 2021)].  Available online:  https://ssrn.com/abstract=3932953.</Citation></Reference><Reference><Citation>Chalder T., Berelowitz G., Pawlikowska T., Watts L., Wessely S., Wright D., Wallace E.P. Development of a fatigue scale. J. Psychosom. Res. 1993;37:147&#x2013;153. doi: 10.1016/0022-3999(93)90081-P.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(93)90081-P</ArticleId><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C. The Chalder Fatigue Scale (CFQ 11) Occup. Med. 2016;65:86. doi: 10.1093/occmed/kqu168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqu168</ArticleId><ArticleId IdType="pubmed">25559796</ArticleId></ArticleIdList></Reference><Reference><Citation>Morriss R.K., Wearden A.J., Mullis R. Exploring the validity of the Chalder Fatigue scale in chronic fatigue syndrome. J. Psychosom Res. 1998;45:411&#x2013;417. doi: 10.1016/S0022-3999(98)00022-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3999(98)00022-1</ArticleId><ArticleId IdType="pubmed">9835234</ArticleId></ArticleIdList></Reference><Reference><Citation>LongCovidSOS  The Impact of COVID Vaccination on Symptoms of Long COVID. An International Survey of 900 People with Lived Experience. 2021.  [(accessed on 8 December 2021)].  Available online:  https://3ca26cd7-266e-4609-b25f-6f3d1497c4cf.filesusr.com/ugd/8bd4fe_a338597f76bf4279a851a7a4cb0e0a74.pdf.</Citation></Reference><Reference><Citation>Li K., Huang B., Wu M., Zhong A., Li L., Cai Y., Wang Z., Wu L., Zhu M., Li J., et al. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Nat. Commun. 2020;11:6044. doi: 10.1038/s41467-020-19943-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19943-y</ArticleId><ArticleId IdType="pmc">PMC7699636</ArticleId><ArticleId IdType="pubmed">33247152</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong Y., Ulasli M., Schepers H., Mauthe M., V&#x2019;kovski P., Kriegenburg F., Thiel V., de Haan C., Reggiori F. Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle. J. Virol. 2020;94:e01925-19. doi: 10.1128/JVI.01925-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01925-19</ArticleId><ArticleId IdType="pmc">PMC6997762</ArticleId><ArticleId IdType="pubmed">31776274</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikegami S., Benirschke R., Flanagan T., Tanna N., Klein T., Elue R., Debosz P., Mallek J., Wright G., Guariglia P., et al. Persistence of SARS-CoV-2 nasopharyngeal swab PCR positivity in COVID-19 convalescent plasma donors. Transfusion. 2020;60:2962&#x2013;2968. doi: 10.1111/trf.16015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.16015</ArticleId><ArticleId IdType="pmc">PMC7461313</ArticleId><ArticleId IdType="pubmed">32840002</ArticleId></ArticleIdList></Reference><Reference><Citation>Matchett W.E., Joag V., Stolley J.M., Shepherd F.K., Quarnstrom C.F., Mickelson C.K., Wijeyesinghe S., Soerens A.G., Becker S., Thiede J.M., et al. Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity. J. Immunol. 2021;207:376&#x2013;379. doi: 10.4049/jimmunol.2100421.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2100421</ArticleId><ArticleId IdType="pmc">PMC8516699</ArticleId><ArticleId IdType="pubmed">34193597</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng K.W., Faulkner N., Cornish G.H., Rosa A., Harvey R., Hussain S., Ulferts R., Earl C., Wrobel A.G., Benton D.J., et al. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020;370:1339&#x2013;1343. doi: 10.1126/science.abe1107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe1107</ArticleId><ArticleId IdType="pmc">PMC7857411</ArticleId><ArticleId IdType="pubmed">33159009</ArticleId></ArticleIdList></Reference><Reference><Citation>Tso F.Y., Lidenge S.J., Pe&#xf1;a P.B., Clegg A.A., Ngowi J.R., Mwaiselage J., Ngalamika O., Julius P., West J.T., Wood C. High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa. Int. J. Infect. Dis. 2021;102:577&#x2013;583. doi: 10.1016/j.ijid.2020.10.104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.104</ArticleId><ArticleId IdType="pmc">PMC7648883</ArticleId><ArticleId IdType="pubmed">33176202</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal A.S., Bradley A.S., Bishop K.N., Kiani-Alikhan S., Ford B. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav. Immun. 2012;26:24&#x2013;31. doi: 10.1016/j.bbi.2011.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2011.06.016</ArticleId><ArticleId IdType="pubmed">21756995</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer R.R., Rock M.A., Vasilevsky N., Carmody L., Rando H., Anzalone A.J., Basson M.D., Bennett T.D., Bergquist T., Boudreau E.A., et al. Characterizing Long COVID: Deep Phenotype of a Complex Condition. eBioMedicine. 2021:74. doi: 10.1016/j.ebiom.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu E.W., van Driel M.L., Staines D.R., Ashton K.J., Ramos S.B., Keane J., Klimas N.G., Marshall-Gradisnik S.M. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J. Transl. Med. 2011;9:81. doi: 10.1186/1479-5876-9-81.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-9-81</ArticleId><ArticleId IdType="pmc">PMC3120691</ArticleId><ArticleId IdType="pubmed">21619669</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandarano A.H., Maya J., Giloteaux L., Peterson D.L., Maynard M., Gottschalk C.G., Hanson M.R. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. J. Clin. Investig. 2020;130:1491&#x2013;1505. doi: 10.1172/JCI132185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI132185</ArticleId><ArticleId IdType="pmc">PMC7269566</ArticleId><ArticleId IdType="pubmed">31830003</ArticleId></ArticleIdList></Reference><Reference><Citation>Cliff J.M., King E.C., Lee J.-S., Sepulveda N., Wolf A.-S., Kingdon C., Bowman E., Dockrell H.M., Nacul L., Lacerda E., et al. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Front. Immunol. 2019;10:796. doi: 10.3389/fimmu.2019.00796.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00796</ArticleId><ArticleId IdType="pmc">PMC6477089</ArticleId><ArticleId IdType="pubmed">31057538</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K.W., Linderman S.L., Moodie Z., Czartoski J., Lai L., Mantus G., Norwood C., Nyhoff L.E., Edara V.V., Floyd K., et al. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells. medRxiv. 2021 doi: 10.1101/2021.04.19.21255739. in press .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.19.21255739</ArticleId><ArticleId IdType="pmc">PMC8253687</ArticleId><ArticleId IdType="pubmed">34250512</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P., Tahmasebi N., Gant V., Gupta R. Long COVID following mild SARS-CoV-2 infection: Characteristic T cell alterations and response to antihistamines. J. Investig. Med. 2021;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan J.M., Mateus J., Kato Y., Hastie K.M., Yu E.D., Faliti C.E., Grifoni A., Ramirez S.I., Haupt S., Frazier A., et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371:eabf4063. doi: 10.1126/science.abf4063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf4063</ArticleId><ArticleId IdType="pmc">PMC7919858</ArticleId><ArticleId IdType="pubmed">33408181</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>